(EMAILWIRE.COM, January 10, 2018 ) The Middle East and Africa Nuclear medicine Radio pharmaceuticals Market is estimated at $495 Million in 2015 and is expected to reach $1.34 billion by 2020, growing at a CAGR of 22.11%. Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

View Full Report @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-nuclear-medicine-radiopharmaceuticals-market-134/

Increasing incidence of cancer and cardiac ailments, immense technological advancements, increasing demand for SPECT and PET applications along with the growing public awareness for healthcare are fuelling the growth of Radiopharmaceuticals market. Further, Integration of X ray tomography (CT) into SPECT have recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework pose a major hurdle to the translational research and clinical investigations and reimbursement issues are blocking the growth of the Radiopharmaceuticals market. In addition, short half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also restraining the Middle-East & Africa nuclear medicine Radioisotopes market.

Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-nuclear-medicine-radiopharmaceuticals-market-134/request-sample

Buy now @ https://www.marketdataforecast.com/cart/buy-now/middle-east-and-africa-nuclear-medicine-radiopharmaceuticals-market-134

Market Segmentation:

By Type
• Diagnostic Radioisotopes
o SPECT
 Technetium-99m
 Thallium-201
 Gallium-67
 Iodine-23
 Others
o PET
 Fluorine-18
 Rubidium-82
 Others
• Therapeutic Radioisotopes
o Beta Emitters
 Iodine-131
 Yttrium-90
 Samarium-153
 Rhenium-186
 Lutetium-177
o Alpha Emitters
 Radium-223
o Brachytherapy
 Cesium-131
 Iodine-125
 Palladium-103
 Iridium-192

By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
• Others

Radiopharmaceuticals market is dominated by diagnostic radioisotopes and is expected to have a market share of 90 % of the radiopharmaceuticals market while therapeutic radioisotopes contribute 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18,Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcome of these tracers has gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market.

Some of the key players influencing the Middle-East & Africa nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results